Development of a protein-coated microcrystal (PCMC) delivery system for full-length recombinant Factor H for use in the treatment of AHUS, dense deposit disease and AMD

Project Details

StatusFinished
Effective start/end date1/08/0930/11/10

Funding

  • UK central government bodies/local authorities, health and hospital authorities: £93,696.00